المؤلفون: D. J Ouyang, Q. T Chen, M. Anwar, N. Xie, Q. C. Ouyang, P. Z. Fan, L. Y. Qian, G. N. Chen, E. X. Zhou, L. Guo, X. W. Gu, B. N. Ding, X. H. Yang, L. P. Liu, C. Deng, Z. Xiao, J. Li, Y. Q. Wang, S. Zeng, Shouman Wang, Wenjun Yi

المصدر: Frontiers in Pharmacology, Vol 12 (2021)

مصطلحات موضوعية: pyrotinib, lapatinib-treated, lapatinib-naive, HER2 breast cancer, metastases, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.682568/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/86d998d85d6c49fd9045d899d8309742

المؤلفون: D. J Ouyang (11335068), Q. T Chen (11335071), M. Anwar (10404872), N. Xie (7698083), Q. C. Ouyang (11335074), P. Z. Fan (11335077), L. Y. Qian (11335080), G. N. Chen (11335083), E. X. Zhou (11335086), L. Guo (4453888), X. W. Gu (11335089), B. N. Ding (11335092), X. H. Yang (11335095), L. P. Liu (11335098), C. Deng (6652631), Z. Xiao (3604901), J. Li (51350), Y. Q. Wang (4918831), S. Zeng (11335101), Shouman Wang (3842485), Wenjun Yi (8888957)

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, pyrotinib, lapatinib-treated, lapatinib-naive, HER2 breast cancer, metastases

Relation: https://figshare.com/articles/figure/Image1_The_Efficacy_of_Pyrotinib_as_a_Third-_or_Higher-Line_Treatment_in_HER2-Positive_Metastatic_Breast_Cancer_Patients_Exposed_to_Lapatinib_Compared_to_Lapatinib-Naive_Patients_A_Real-World_Study_pdf/16443816

الاتاحة: https://doi.org/10.3389/fphar.2021.682568.s001

المؤلفون: Zhonghua Tao, Leiping Wang, Sheng Zhang, Ying Lin, Jun Cao, Mingxi Lin, Biyun Wang, Xichun Hu, Jian Zhang, Yiqun Du

المصدر: Cancer Research and Treatment : Official Journal of Korean Cancer Association

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, medicine.medical_treatment, Biopsy, Tyrosine kinase inhibitor, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Breast, skin and connective tissue diseases, Aged, 80 and over, Brain Neoplasms, Brain, Vinorelbine, Middle Aged, Neoadjuvant Therapy, Progression-Free Survival, 030220 oncology & carcinogenesis, Aminoquinolines, Female, Original Article, medicine.drug, Adult, medicine.medical_specialty, China, Lapatinib-treated, Breast Neoplasms, Lapatinib, Disease-Free Survival, Capecitabine, 03 medical and health sciences, Young Adult, Breast cancer, Internal medicine, Breast Cancer, Humans, HER2-positive breast cancer, Aged, Acrylamides, business.industry, Brain metastasis, Cancer, Chemoradiotherapy, Adjuvant, Trastuzumab, Pyrotinib, medicine.disease, Radiation therapy, Regimen, 030104 developmental biology, Drug Resistance, Neoplasm, Neoplasm Recurrence, Local, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b0ec3e17462dd70f49ddd17bb07aeee
https://pubmed.ncbi.nlm.nih.gov/32340083